Your browser doesn't support javascript.
loading
TACE plus PD-1 inhibitor (Camrelizumab) treatment for bridging to tumor resection in HCC: Case reports.
Xin, Haibei; Zhang, Cunzhen; Ding, Zhiwen; Zhang, Minfeng; Ding, Guanghui; Li, Nan.
Afiliación
  • Xin H; Department of Hepatic Surgery I (Ward I), The Third Affiliated Hospital of Naval Military Medical University, 700 Moyu Road, Jiading District, Shanghai 201805, China.
  • Zhang C; Department of Hepatic Surgery I (Ward I), The Third Affiliated Hospital of Naval Military Medical University, 700 Moyu Road, Jiading District, Shanghai 201805, China.
  • Ding Z; Department of Hepatic Surgery I (Ward I), The Third Affiliated Hospital of Naval Military Medical University, 700 Moyu Road, Jiading District, Shanghai 201805, China.
  • Zhang M; Department of Hepatic Surgery I (Ward I), The Third Affiliated Hospital of Naval Military Medical University, 700 Moyu Road, Jiading District, Shanghai 201805, China.
  • Ding G; Department of Hepatic Surgery I (Ward I), The Third Affiliated Hospital of Naval Military Medical University, 700 Moyu Road, Jiading District, Shanghai 201805, China.
  • Li N; Department of Hepatic Surgery I (Ward I), The Third Affiliated Hospital of Naval Military Medical University, 700 Moyu Road, Jiading District, Shanghai 201805, China. Electronic address: liparislisi@aliyun.com.
Clin Res Hepatol Gastroenterol ; 46(1): 101777, 2022 01.
Article en En | MEDLINE | ID: mdl-34333197
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Quimioembolización Terapéutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Humans Idioma: En Revista: Clin Res Hepatol Gastroenterol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Francia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Quimioembolización Terapéutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Humans Idioma: En Revista: Clin Res Hepatol Gastroenterol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Francia